PSA “transformation” underway

THE Pharmaceutical Society of Australia (PSA) is undergoing an “operational transformation” designed to strengthen the advocacy and training it provides its members.

In a statement issued to Pharmacy Daily, PSA National President, Dr Chris Freeman, confirmed the organisation has commenced a restructure ahead of its involvement in negotiations with the Federal Government and Pharmacy Guild of Australia over the Seventh Community Pharmacy Agreement (7CPA).

“Dr Shane Jackson will remain as PSA’s CEO through to at least the end of 2019, to drive the 7CPA negotiations, and guide the operational transformation that will build a stronger Society,” he said.

“PSA’s operational transformation is focussed on delivering value for our members across advocacy, policy, education and training within the PSA. The transformation includes significant investment in our digital offering and member experience.”